Vanni is a Principal in the Medicxi investment team with main focus on growth stage clinical opportunities. Prior to joining Medicxi, Giovanni was a Principal with Index Ventures, having joined the firm in 2012. Before that he was at Cancer Research UK's London Research Institute (LRI; now the Crick Institute). At the LRI he conducted research focused on vascular biology and angiogenesis, whilst also delivering competitive intelligence projects to biopharmaceutical companies in the oncology field. Giovanni currently sits on the board of directors of Gadeta, SuperX, Kymo Therapeutics and Janpix.
He obtained a BSc in Biochemistry from Imperial College London and a PhD in Biochemistry and Molecular Biology from University College London.